Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell TransplantationRainer Storb, Brenda M. Sandmaier, Thomas R. Chauncey et al.|Journal of Clinical Oncology|2013Cited by 212
Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experienceBeatriz Morillo-Gutiérrez, Mary Slatter, Rita Beier et al.|Blood|2016Cited by 134
Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decadesJason P. Cooper, Brenda M. Sandmaier, Barry E. Storer et al.|Haematologica|2020Cited by 39